VEGFA and diabetes mellitus: No significant differences were found between the groups regarding age, sex, glycated hemoglobin (HbA1c), duration of diabetes (DM), proliferative membrane grading, macular involvement, number of retinal detachments, lens status, best-corrected visual acuity (BCVA), intraocular pressure, prior anti-VEGF treatment, or preoperative panretinal photocoagulation (PRP).